To bridge the gap between the healthcare industry and the women’s health community, and in recognition of industry’s significant contribution to the nation’s health care system, SWHR formed the Corporate Advisory Council (CAC) in 1991. The mission of CAC is to engage the resources of the health care industry and its suppliers in collaboration with SWHR to spearhead changes to improve women’s health and research. CAC meets annually with SWHR representatives and other essential decision-makers to discuss issues that affect research on women’s health. Additional opportunity for dialogue on specific government relations and communication issues affecting women’s health research is provided through CAC sub-committees that meet frequently throughout the year.

Member Benefits

Working together for our common goals, CAC members are proud to say they care about women’s health and appreciate the opportunity to expand that commitment through their membership. Through this partnership, they work to communicate to the public vital women’s health information and their dedication to advancing women’s health through expanded research. SWHR CAC members find that their participation provides additional rewards, including recognition in SWHR publications and first opportunities to sponsor individual initiatives, meetings, or events.

SWHR considers women’s health to include any disease or conditionthat affects women solely, predominantly or differently, and works to:

  • Increase public and private funding for research on women’s health;
  • Promote the appropriate inclusion of women in medical research studies and sex-based analysis of research findings; and
  • Encourage the study of sex-based biology in basic research, disease etiology, and response to medical interventions.

By becoming a member of SWHR’s Corporate Advisory Council (CAC), the company will:

  • Engage in regular dialogue with SWHR and other CAC members through CAC sub-committees about mutual interests and concerns in the areas of government affairs and the communication of women’s health research concerns to the public;
  • Assist SWHR in educating leaders in women’s health on policy issues through legislative briefings and receive regular updates through the Women’s Health Research Coalition Hotline on issues affecting women’s health research, including developments on Capitol Hill, as well as activities at the National Institutes of Health (NIH), Food and Drug Administration (FDA), and other government agencies;
  • Have access to current and cutting edge information about the latest findings in women’s health through the Women’s Health Research News Syndicate and proceedings from SWHR meetings; and
  • Partner with SWHR to aid the development of your company’s women’s health initiatives and raise awareness about women’s health issues and have the opportunity to share your company’s expertise at SWHR-sponsored meetings and education programs.

Corporate Advisory Council Members

Premium Members:

  • Allergan, Inc.
  • Eli Lilly and Company
  • PhRMA


  • Amgen
  • Astellas
  • Boehringer Ingelheim
  • Bristol Myers Squib
  • Cardio DX
  • Intercept
  • Hologic, Inc.
  • Kimberly-Clark
  • Novartis
  • Takeda Pharmaceuticals North America, Inc.
  • TherapeuticsMD
  • Valeant

For more information on CAC membership, please contact Joy Braun, Development Manager at joy@SWHR.org.